Regenetp Inc (RGTPQ)

[slow_feet]

Buy volume increasing, calls trading...

[slow_feet]

PTE -- This c&h/pennant is getting ready to make a decision...



Fairly large open interest on May/August 2.5 calls

[XFundManager]

PolarityTE: Will This Biotech Be The Next Amazon Or Tesla?

Trading Under the Ticker Symbol PTE at a price of $1.10

"We believe that PolarityTE can revolutionize the field of regenerative medicine; our target price is $70." – Elemer Piros, Cantor Fitzgerald

PolarityTE: Will This Biotech Be The Next Amazon Or Tesla?
Jeff Dyer and Hal Gregersen
Jeff Dyer and Hal GregersenFormer Contributor
Leadership
We write about innovation based on research from The Innovator's DNA.
uncaptioned
By Jeff Dyer

Did Johns Hopkins dropouts just deliver the paradigm shift in disruptive biotechnology, a new model for public launch, and the beginning of a biotech boom?

“You realize this is irreversible — right?” Were the last words that Drs. Denver Lough MD, PhD and Ned Swanson MD heard as they handed in their resignations from the world-renowned Johns Hopkins Hospital Department of Plastic and Reconstructive Surgery.

It was really hard to walk away — I had put 17 years into becoming a plastic and reconstructive surgeon and was finally in the foremost program at the world’s greatest hospital, surrounded by amazing leaders in the field,” said Lough. “How could I possibly justify giving that up to everyone who had sacrificed so much for me to get there.

But on December 1st of 2016, Lough and Swanson were catapulted instantaneously from coveted Plastic Surgery resident positions to the CEO and COO of Majesco Entertainment Co. (Nasdaq:COOL) in hopes that a merger between a 31-year-old failing gaming company and their own revolutionary technology would provide the field of medicine with the ability to regenerate new tissue — skin, bone, muscle, etc. Lough and Swanson are taking a huge gamble because the culture in the medical community is that you don’t leave to try a start-up and then come back if it doesn’t work. Indeed, in 92% of the last 100 life science start-ups to go public, the MD inventor of the flagship product didn’t work for the company. This is startling because in virtually 100% of high tech start-ups that go public, the founder-inventor does work for the company and is viewed as a valuable resource (can you imagine Amazon without Jeff Bezos? Tesla without Elon Musk? Facebook without Zuckerberg?). But the risks of leaving a medical institution are so high — because there is no way back — that most life science inventors don’t take the risk. As a result, most inventors turn their technologies over to VC firms to take them forward — and consequently they typically end up with less than 5% equity in the start-up. Of the last 50 biotech startups, only about 14% launched without funding from VC firms (and only 4% without either VC or Angel investors). PolarityTE was one of only four life science firms that went public immediately without an Initial Public Offering (IPO). So why were Dr. Lough and Dr. Swanson willing to take the huge risk of leaving lucrative plastic surgery positions with no way back? And is the way they launched PolarityTE a new superior model for launching a biotech start-up?

[ClayTrader]

* * $PTE Video Chart 01-08-2021 * *

Link to Video - click here to watch the technical chart video

[trendzone]

Part of the reason why it's moving higher today, and why flipbags may lose out big time.

PTE Stock Alert: 7 Things for Investors to Know About PolarityTE as Shares Soar

1/8/2021 11:54am EST

By William White, InvestorPlace Writer

PolarityTE (NASDAQ:PTE) stock is soaring higher on Friday despite a lack of news concerning the company.

??

Source: Bukhta Yurii / Shutterstock.com

The increasing price in PTE stock comes as shares experience heavy trading today. That’s resulted in more than 36 million shares of the stock changing hands today. For comparison, the stock’s daily average trading volume is 1.71 million shares.

So why exactly are investors taking such an interest in PTE stock today? It all likely has to do with the upcoming H.C. Wainwright Virtual Bioconnect Conference. This conference is set to take place on Monday and PolarityTE will be presenting at it. Investors are likely boosting the stock up in preparation for good news at the event.

Potential investors in PTE stock may want to know a little more about the company before diving in. Luckily, we have a quick overview of PolarityTE below.

PolarityTE is a commercial-stage biotech company focused on the research and development of regenerative tissue products.

The company does so not by using artificial or synthetic tissue but from tissue taken from each patient.

It was founded in 1998 and operates out of Salt Lake City, Utah.

PolarityTE is led by CEO David Seaburg

Prior to joining the company, he worked for 25 years at Cowen Inc (NASDAQ:COWN) under various roles.

Those roles include managing director, head of sales trading, and as part of its Equity Operating Committee.

The company’s current market capitalization is sitting at $53.18 million.

PTE stock was up 60.4% as of noon Friday.

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article.

?Subscribe 

[janeyH]

just bought 2 days ago - sometimes you just get lucky!!

quite the run today.

[slow_feet]

Company Press Releases

[xray168]

paid a penny

[3antar]

Nice catch

[Spumoni]

Looking good in AH trading something good must be happening soon!

[Cclr0007]

You’re so dam right ! appetite is rising!

[Cclr0007]

PTE is in turnaround mode like VCEL but with a lot more potential ! No more Citron Research, no more unwarranted lawsuits, battleproof management, FDA pre- INDeed, First USA Patent, massive SkinTE potential in Diabetic Foot Ulcer...and more...

[BearRifle]

Don't give up on PTE y'all. This thing is a listed stock under $1 with increasing revenue and major upside potential with FDA approval.

Also note: LOW-ISH Float (24 million)

This sucker could run

[xray168]

2.50 calls still getting gobbled for DEC and JAN

[xray168]

Getting close to that time again...

[slyguy8888]

I think the unusual optons activity should be noted

[ClayTrader]

* * $PTE Video Chart 07-24-2020 * *

Link to Video - click here to watch the technical chart video

[Papalaka]

$PTE - KABBBBBOOOOOOOMMMMMMM!!!!!!!!!!!

[Papalaka]

$PTE PolarityTE will issue a press release announcing top-line data on Friday, July 24th at 8:00 am ET, and will also host a conference call and webcast to discuss the results with Dr. Armstrong at 4:30 pm ET on Monday, July 27th. The conference call can be accessed by calling 1-888-599-8688 (U.S. and Canada), with confirmation code 552780 and referencing “PolarityTE DFU Interim Data Conference Call.” A webcast of the conference call can be accessed by using the link below.

[ClayTrader]

* * $PTE Video Chart 07-20-2020 * *

Link to Video - click here to watch the technical chart video

[Papalaka]

Weeeeeeeeeeeee

[Papalaka]

The next few weeks are going to be fun!

[Phoenix300]

Perfect flip

[Phoenix300]

Allllllllllllll aboard !!!!

[Phoenix300]

BOOM!!!! GATEMORE CAPITAL MANAGEMENT LLP filed 13/d !!!!

[Phoenix300]

$PTE looking to make the next move up. $2.00 coming.

[G-Schmoney]

PTE WHALES ON THE BID!! LET'S GO!

[Phoenix300]

$PTE up 12% with bid support.

[Phoenix300]

Something is brewing here.

[Papalaka]

Looking good here, Cantor Fitz $9 PT!

[sparks454]

Some good news..

https://www.businesswire.com/news/home/20200413005104/en/

[ClayTrader]

* * $PTE Video Chart 02-12-2020 * *

Link to Video - click here to watch the technical chart video

[Chrisny73]

Looks like a nice buying opportunity here.... nice long term outlook

[TommyBoyTrader9460]

Took $pte here at $4.15 for the next leg up...

[ClayTrader]

* * $PTE Video Chart 01-16-2020 * *

Link to Video - click here to watch the technical chart video

[wesley_]

$4.14 nice hod :)

[Country Squire]

Great Call *** you woke it up … 4.700,000 short if that's correct . ty

[Longoo]

This board should wake up soon!! Gonna get busy around here! Look at the new management team and reflect awhile. David Seaburg, Cowen, inc. (President). Peter Cohen (Leahman, Raimus, Cowen, etc) Chairman. Ned Swanson (founder), Willie Bogan, Jon Mugford, etc. It's a commercialization Dream Team developing a great science that works and these Wall Street Power Players aren't here for no reason. They know there's something big about to happen. It will take awhile to scrub off the smell of the recent attacks and the shorts will be back to feed again but it won't mean a thing in 5 years. Get on board while the getting is good or be left behind soon IMHO.
Do your research and good luck to all.

[Gcasa]

Thin

[XenaLives]

Another stock scammer Reed Wallace - I suspect the Leviev foundation was a money laundering mechanism for him:


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=84471904

[Steponit]

I don't know why this is dropping so low. But I'm holding. The company is definitely growing, and they have a ton of really talented people working there. It's costing them a lot to grow, but I think it'll pay off long term. They might be getting some competition from AVMXY who has a similar product for burn patients. But PTE is also working on regenerative bone and organs, as well as doing contractual research in their labs as an additional source of income. I'm going to continue holding long term. The drop might also be a sector-wide drop, as AVMXY also started to drop some the past few days for no real reason.

[Porterhouse10]

What are your thoughts down here?

[doubleb73]

Totally agree. Listen to the last earnings conference call. It is about an hour, but truly impressive. They had all their c suite executives speak. They have a clear road map for this company to make it a platform company. This company added new executives over the last year will impressive resumes.

[thought013]

Very well said, completely agree.

[Steponit]

They're in the very early stages of getting a revenue stream going. By the dip in the price, it seems obvious that PTE shareholders aren't happy with the level of revenue. But, jeez, they're just getting started. It takes time. They're working only regionally now. This should grow exponentially as they start adding more regions, and as it gains wider acceptance. It's tough to come in with a completely new way of doing things and get a huge bureaucracy of health care providers to get on board with it right away. But I think once everyone realizes this is a better solution than all previous methods, and that it works better for the patient, lessens the lengths of hospital stays, and lowers the overall cost of treatment, that eventually everyone will get on board with them. I think this eventually will turn around and jump way up. I'm not going to sell now. I'll hold for however long it takes. Eventually this will be a huge company.

[Steponit]

Tons of institutional investors in this.

[tdeck]

Will look to short 18-20

[Steponit]

Up she goes.

[Cclr0007]

Great 4Q report! net loss $22.5M, Revenue $1.1M beat by$0.3M!!!

[montanus]

Alpha Capital fraudulent Martin Shlomo Schlaff and fraudulent Jesselsons, Honig, Maza

Stocks manipulation, stealing assets...
ILNS (HONIG,SCHLAFF,MAZA,JESSELSON,...)
MGTI
PTE
RIOT
BIOZONE
...............


https://www.haaretz.com/israel-news/.premium-interior-minister-dery-hasn-t-learned-from-the-past-1.6675204

https://en.globes.co.il/en/article-370042

https://www.haaretz.com/1.4711623

https://www.addendum.org/kern/schlaff-alpha-capital/


https://www.marketwatch.com/story/sec-charges-multiple-firms-individuals-with-microcap-fraud-schemes-including-barry-honig-2018-09-07

https://www.miaminewtimes.com/news/miami-billionaire-phillip-frost-sued-for-additonal-stock-fraud-10971262